CompletedNot applicableNCT06393114

Impacts of Fermented Oat-based Product on Gut Microbiota and Health

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Eastern Finland
Principal Investigator
Marjukka Kolehmainen
Professor
Intervention
Fermented oat-based product(other)
Enrollment
57 enrolled
Eligibility
30-65 years · All sexes
Timeline
20242024

Study locations (1)

Collaborators

University of Turku · Umeå University · ETH Zurich · KU Leuven

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06393114 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome

← Back to all trials